SCHEMBL1638197

SCHEMBL1638197

Cc1nccc(I)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9355962 0.72 KDM4E (0.53)
SCHEMBL29895688 0.72
SCHEMBL30386373 0.72
SCHEMBL196153 0.72
SCHEMBL433889 0.72
Phosphine SCHEMBL29249462 0.70
Ammonia Solution, Strong SCHEMBL7855111 0.70
Bromide SCHEMBL27691215 0.70
Hydrochloric Acid SCHEMBL8589457 0.70 GRM4 (0.41)
Hydrogen Sulfide SCHEMBL27594968 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488510-B1 Amides and thioamides as pest control agents BAYER IP GMBH (DE) 2017-03-29 EP claimed
EP-2725022-B1 New amides as pest control agents BAYER CROPSCIENCE AG (DE) 2017-03-29 EP claimed
EP-2297130-B1 NEW HETEROAROMATIC AMIDES AND THIOAMIDES AS PEST CONTROL AGENTS BAYER CROPSCIENCE AG (DE) 2014-09-17 EP claimed
US-20230339936-A1 COMPOUND HAVING KINASE INHIBITORY ACTIVITY CYTOSINLAB THERAPEUTICS CO., LTD. (CN) 2023-10-26 US disclosed
WO-2023205778-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 WO disclosed
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed
US-11696458-B2 Organic light-emitting device and method of manufacturing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-04 US disclosed
US-11678498-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-13 US disclosed
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-28 US disclosed
US-11588118-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-02-21 US disclosed
EP-3723783-B1 MITOCHONDRIA-TARGETING PEPTIDES STEALTH BIOTHERAPEUTICS INC (US) 2023-02-15 EP disclosed
WO-2010120935-A1 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2010-10-21 WO disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-6891039-B2 Imidazo [4,5-B] pyridine compounds and their pharmaceuticals use NOVARTIS AG (CH) 2005-05-10 US disclosed
US-20040082604-A1 Thiazole and imidazo (4,5-B) pyridine compounds and their pharmaceutical use REVESZ LASZLO (CH) 2004-04-29 US disclosed
US-6608072-B1 Inhibiting production of soluble tumor necrosis factor or reducing inflammation NOVARTIS AG (CH) 2003-08-19 US disclosed
US-6570015-B2 Reacting alpha-keto ester with an isothiourea UBE INDUSTRIES, LTD. (JP) 2003-05-27 US disclosed
US-20030055252-A1 Process for producing 2-substituted thiopyrimidine-4-carboxylate UBE INDUSTRIES, LTD. (JP) 2003-03-20 US disclosed
EP-1224185-A1 THIAZOLE AND IMIDAZO[4,5-B]PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE Novartis AG (CH) 2002-07-24 EP disclosed
WO-2001030778-A1 THIAZOLE AND IMIDAZO [4,5-B] PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE NOVARTIS AG (CH) 2001-05-03 WO disclosed